Skip to main content

Aurora Spine Corporation(ASG-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.255
Day High0.255
Open:0.255
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
GlobeNewswire
Aurora Spine Announces Issuance of Fourth U.S. Patent Covering DEXA Technology® Bone Density-Matched Implants
GlobeNewswire
Aurora Spine Corporation Announces Record Fourth Quarter and FY25 Financial Results
GlobeNewswire
Aurora Spine Corporation Schedules Release of Fourth Quarter and Fiscal 2025 Financial Results
Newsfile
Upcoming Meeting Dates - April 20, 2026
GlobeNewswire
Aurora Spine Corporation to Participate in the 38th Annual ROTH Conference
GlobeNewswire
AURORA SPINE CORPORATION ANNOUNCES AMENDMENT TO LOAN FROM INSIDER
GlobeNewswire
Aurora Spine Announces Issuance of Two U.S. Patents
GlobeNewswire
Aurora Spine Corporation Announces Record Third Quarter Financial Results
GlobeNewswire
Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting
GlobeNewswire
Aurora Spine Launches New Biologics Portfolio
GlobeNewswire
Aurora Spine Announces Proposed Warrant Extension
GlobeNewswire
Aurora Spine Announces Launch of its DEXA-L™ Anterior Lumbar Interbody Fusion Device
GlobeNewswire
Aurora Spine Corporation Announces Record Second Quarter Financial Results
GlobeNewswire
Aurora Spine Announces Participation in 7th Annual American Society of Pain & Neuroscience Conference
GlobeNewswire
Aurora Spine Surpasses 1,500 Successful Surgeries Using DEXA-C™
GlobeNewswire
Aurora Spine Surpasses Milestone of 2,500 Procedures Using SiLO™ SI Joint Fusion System
GlobeNewswire
Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2025 Financial Results
AI-generated - The Globe and Mail
Aurora Spine: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (ASG)
GlobeNewswire
Aurora Spine Corporation Announces Fourth Quarter and Fiscal Year 2024 Financial Results

Profile

Aurora Spine Corp is engaged in the development, manufacture, and selling of minimally invasive, interspinous fusion systems and devices. These 510K and patent protected medical devices improve patient outcomes in the area of spine and sacroiliac joint surgical procedures. The company is focused on bringing new solutions to the spinal implant market through a series of minimally invasive, regenerative spinal implant technologies.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.